Drug intelligence / Profile preview

quercetin pentaacetate

Development stage
Preclinical
Modality
Small Molecules
Administration
In Vitro Only
01

Overview

Quercetin pentaacetate is a **synthetic, pentaacetylated derivative of the natural flavonoid quercetin**. It demonstrates **diverse biological activities**, including **antioxidant, anti-inflammatory, antiviral, and anticancer properties**[4][5][8][10][13]. This compound shows potent *in vitro* inhibition of lipid peroxidation and scavenges radicals; it inhibits LPS-induced nitrite and PGE2 production, and downregulates iNOS and COX-2 expression in immune cells[4][10]. Notably, quercetin pentaacetate **blocks the adhesion of respiratory syncytial virus (RSV) to cell surfaces** by binding the viral F-protein with high affinity, impeding infection[5][8][9]. It shows **higher metabolic stability and reduced cytotoxicity versus quercetin**. Additional in vitro work shows antiproliferative effects against various cancer cell lines[4][10]. Research remains at the preclinical stage; development status for any human therapeutic indication is unreported.

Other names
PentaacetylquercetinQuercetin acetate3,3',4',5,7-Pentaacetoxyflavone3,3',4',5,7-Penta(acetyloxy)flavonePeracetylated Quercetin3,5,7-triacetoxy-2-(3,4-diacetoxy-phenyl)-chromen-4-one2-(3,4-diacetoxyphenyl)-4-oxo-4H-chromene-3,5,7-triyl triacetate[2-acetyloxy-4-(3,5,7-triacetyloxy-4-oxochromen-2-yl)phenyl] acetate
02

Targets

NOS2 (Nitric Oxide Synthase 2)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)RSV F (Respiratory syncytial virus fusion protein)NOS1 (nNOS)PI3K (Phosphoinositide-3-kinase regulatory subunit 6)PIKFYVE (Phosphoinositide kinase, FYVE-type zinc finger containing enzyme)

Beyond the preview

Go deeper on quercetin pentaacetate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on quercetin pentaacetate.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call